Introduction

Posterior chamber intracapsular intraocular lens (IOL) implantation remains the ideal outcome following cataract extraction. However, following complicated cataract surgery, predominantly after posterior capsule rupture with or without displacement of nuclear fragments, there may be insufficient remaining capsular support for either intracapsular or posterior chamber sulcus placement of the IOL. A similar scenario is also frequently encountered following pars plana vitrectomy for retrieval of displaced nuclear fragments and congenital subluxated lenses.

In such cases, alternative methods of IOL fixation must be considered. These include sutured scleral fixation, anterior chamber sulcus placement and iris fixation.

Previously, iris fixation was achieved using closed-loop anterior chamber IOLs, with the loops being positioned anterior and posterior to the iris. Pupil dilation carried the risk of IOL displacement and this type of lens fell out of favour in the mid 1980s following numerous reports of significant complications in the post-implantation period.1

An alternative method of iris fixation involves claw shaped haptics attached to the mid-peripheral iris. This method of fixation also confers the benefit of easy pupil dilation.

We describe our experience with the Artisan aphakia iris claw lens (Ophtec, Groningen, the Netherlands).

Patients and methods

All cases of Artisan lens implantation performed over a four-year period at Leicester Royal Infirmary were identified from the operating theatre logbook. In total, 43 patients were identified, of which 38 sets of case notes were retrievable detailing Artisan implantation in 39 eyes. From these, pre- and post-operative data were retrieved, including demographics, pre-existent ocular comorbidity and post-operative complications. The aetiology of aphakia was identified in each case. Best-recorded visual acuity was noted before and after IOL implantation.

All procedures were performed by the same consultant surgeon using a standardised technique that, in summary, comprised: a 5.2 mm chord length half-thickness limbal section, creation of two small corneal paracenteses at 2 and 10 o’clock, followed by full thickness completion of the superior corneal incision; injecting intracameral acetylcholine chloride 1%, then cohesive viscoelastic into the anterior chamber (AC); inserting the lens implant vertically into the AC; rotating the IOL such that the claw haptics are orientated dependant on the amount of iris tissue present; enclavation of the iris between the claws; creation of a superior peripheral iridotomy; suturing the large corneal wound; and washing out the AC.

In some patients, pars plana or anterior vitrectomy was required before lens insertion, in which case the pupil was dilated pre-operatively and intracamerally. Miochol was injected following vitreous clearance.

Results

In total, 39 eyes in 38 patients were analysed. In total, 19 patients were male and 20 were female. Their ages ranged from 22 to 98 years, mean 62.5 years.

Follow-up ranged from 3 to 36 months, mean 15.7 months.

The aetiology of (effective) aphakia is detailed in Table 1. A total of six patients had pre-existing glaucoma or ocular hypertension. Other pre-existing ocular pathology is outlined in Table 2.

Table 1 Aetiology of aphakia
Table 2 Pre-existing ocular comorbidity

Of the 39 eyes, 26 (66.6%) achieved a final visual acuity better than the pre-operative best recorded visual acuity. A total of 12 eyes (30.8%) achieved a final acuity equal to that measured pre-operatively, and only 1 eye (2.6%) ended up with a poorer final acuity (see Figure 1). This patient had Marfan's syndrome and was diagnosed with non-arteritic anterior ischaemic neuropathy shortly after Artisan implantation. It is possible that this developed during the course of general anaesthesia for the procedure. The majority of patients were operated on under local anaesthesia and all were elective procedures.

Figure 1
figure 1

Pre-operative vs final VA.

Of the 39 eyes, 25 (64.1%) achieved a post-operative visual acuity equal to or better than 6/12. Of these, two eyes had ocular co-pathology. One eye was amblyopic and had undergone congenital cataract extraction; the other eye had dry macular degeneration. A total of 14 eyes (35.9%) achieved final visual acuities worse than 6/12, of which 12 eyes (85.7%) contained ocular co-pathology as previously detailed (see Table 3).

Table 3 Patients with final VA worse than 6/12

Apart from the patient with Marfan's syndrome described above, no other patient developed any additional pathology following Artisan implantation. There were no intra-operative complications in this case series. No cases of uveitis, hyphaema, or post-operative glaucoma were identified in any patient. No cases of post-operative hypotony were reported —all cases measured intra-ocular pressures within the normal range at final follow-up. No cases of cystoid macular oedema or corneal decompensation were seen.

Discussion

The aim of Artisan aphakia lens implantation is to achieve acceptable refractive and visual outcomes in patients with insufficient capsular support for intracapsular or sulcus IOL placement, while avoiding the need for aphakic spectacles or contact lenses. It is a vaulted convex–concave design—5 mm optic with an overall diameter of 8.5 mm, including the haptics. The haptics are designed as pincers or claws, which grasp the immobile part of the peripheral iris thus avoiding the difficulties in pupil dilation experienced with iris clip lenses and enable excellent fundal visualisation.

In our series, 66.6% of patients achieved a final acuity better than that recorded pre-operatively. However, not every patient underwent measurement of their best-corrected visual acuity (BCVA) with pre-operative spectacle refraction. This was particularly the case in patients without ocular comorbidity who required Artisan implantation following complicated phacoemulsification surgery. Thus, the percentage of patients improving on their pre-operative best-recorded visual acuity may be artificially elevated. Nevertheless, the overall proportion of patients achieving final acuities of 6/12 or better, 64.1% is highly encouraging.

If we consider the number of patients without pre-operative ocular comorbidity, the proportion of patients achieving 6/12 or better increases to 85.2%, which is comparable to the 85% of patients achieving the same level of acuity in the National Cataract Surgery Survey (NCSS),2 although not quite as good as the 92% attaining that level as their final refracted acuity. Not all patients in this series underwent final refraction before discharge and it is possible that further improvement was achieved.

However, the group of patients with pre-operative ocular comorbidity fared considerably worse, with only 16.7% achieving an acuity better than or equal to 6/12, compared with the 65% (77% at final refracted acuity) in the NCSS.2 This low figure reflects the type of comorbidity as previously detailed and also clearly highlights the relationship between comorbidity and poor visual outcome.

One particular concern with all types of anterior chamber lens is a reduction in corneal endothelial cell density. In this series, specular microscopy and corneal thickness measurements were not routinely performed and we are unable to comment on any such changes.

However, some studies have demonstrated a reduction in cell density. One series was performed on nine eyes with traumatic lens subluxation and showed reductions in density of 15% at 1 month and 14% at 12 months post-operatively.3 Another study reported on 26 eyes where Artisan phakic lens implantation was performed for moderate to high myopia, with a reduction in cell density of 14.05% after 5 years.4 A third study of 67 eyes with phakic lens implantation reported a density reduction of 10.9% at 3 years.5 As the latter two studies looked at phakic lens implants, the data is not directly comparable.

Most studies found by the authors suggested stability of endothelial cell counts, although again these were reporting findings in phakic eyes undergoing refractive surgery; those with reasonably large numbers of enrolled patients (155 and 90 eyes) did not demonstrate any significant loss of cell density.6, 7 Another study reported stabilisation to physiologically normal levels at 3 years in 129 eyes.8 The longest follow-up period of any series was 9.5 years in 3 children who underwent Artisan lens implantation following congenital cataract extraction, and reported no difference in cell count when compared to the unoperated eye.9

Other potential complications following Artisan aphakia lens implantation include uveitis, glaucoma, hyphaema, and cystoid macular oedema. Although there have been some case reports of such developments,10, 11 including a case of pupillary block glaucoma following a phakic implantation,12 no large series have reported a significant incidence of these, and we have not encountered such complications to date. In our series, a surgical PI should preclude the possibility of pupillary block.

There are alternatives to Artisan aphakia IOL placement, including angle-fixated AC IOLs and scleral-fixated posterior chamber IOLs (SPCIOLs). Complications following angle placement of AC IOLs include corneal decompensation, uveitis, secondary glaucoma, distorted pupil, cystoid macular oedema, and retinal detachment.13

Yang et al14 reported a series of 65 eyes in 61 patients who underwent SPCIOL placement, with 66% of the patients achieving improved or unchanged BCVA at the final follow-up. In total, 37% of patients experienced pre- or post-operative adverse events. Their methodology and patient cohort (non-vitrectomised eyes) were sufficiently different from ours to prevent a direct comparison of outcomes, but placement of SPCIOLs requires more surgical manipulation and carries the risk of vitreous traction with the possibility of ensuing rhegmatogenous retinal detachment.15 Other possible complications include tilting of the implant, decentration, or dislocation, and transscleral suture erosion.

Conclusion

This study shows that Artisan aphakia lens implantation is capable of delivering good visual outcomes with a low complication rate in patients who are unable to undergo intracapsular or sulcus IOL positioning. A prospective study, including serial endothelial cell density measurement, morphology, and corneal thickness would provide further useful information on the long-term safety in pseudophakic patients.

Table 4 Summary